Acceptable performance of VITEK 2 system to detect extended-spectrum β-lactamases in clinical isolates of Escherichia coli: A comparative study of phenotypic commercial methods and NCCLS guidelines

Diagnostic Microbiology and Infectious Disease

Volumn 51, Issue 3, 2005, Pages 191-193

  Sorlózano, Antonio ^a   Gutiérrez, José ^a   Piédrola, Gonzalo ^a   Soto, María José ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

ESBL; Escherichia coli; Etest; VITEK 2

Indexed keywords

BETA LACTAMASE;

ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ESCHERICHIA COLI; NONHUMAN; PHENOTYPE; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL;

EID: 17644369650     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2004.11.001     Document Type: Article

References (12)

1. P.A. Bradford Extended-spectrum β-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat Clin Microbiol Rev 14 2001 933 951
2. M.W. Carter, K.J. Oakton, M. Warner, and D.M. Livermore Detection of extended-spectrum β-lactamase in Klebsiellae with Oxoid combination disk method J Clin Microbiol 38 2000 4228 4232
3. M.G. Cormican, S.A. Marshall, and R.N. Jones Detection of extended-spectrum beta-lactamases (ESBL) producing strains by Etest ESBL screen J Clin Microbiol 34 1996 1880 1884
4. V. Jarlier, M.H. Nicolas, G. Fournier, and A. Philippon Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns Rev Infect Dis 10 1988 867 878
5. M.A. Leverstein-van Hall, A.C. Fluit, A. Paauw, A.T. Box, S. Brisse, and J. Verhoef Evaluation of the Etest ESBL and the BDPhoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum β-lactamases in multiresistant Escherichia coli and Klebsiella spp J Clin Microbiol 40 2002 3703 3711
6. D.M. Livermore, M. Struelens, and J. Amorim Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests J Antimicrob Chemother 49 2002 289 300
7. P.R. Murray, E.J. Baron, J.H. Jorgensen, M.A. Pfaller, and R.H. Yolken Manual of clinical microbiology 8th ed 2003 ASM Washington (DC)
8. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing Approved standard M100-S14 2004 NCCLS Wayne (PA)
9. D.L. Paterson, and V.L. Yu Extended-spectrum β-lactamases: A call for improved detection and control Clin Infect Dis 29 1999 1419 1422
10. D.L. Paterson, W.C. Ko, and A. Von Gottberg Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: Implications for the clinical microbiology laboratory J Clin Microbiol 39 2002 2206 2212
11. C.C. Sanders, M. Peyret, and E.S. Moland Ability of the VITEK 2 Advanced Expert System to identify β-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa J Clin Microbiol 38 2000 570 574
12. E. Vercauteren, P. Descheemaeker, M. Ieven, C.C. Sanders, and H. Goossens Comparison of screening methods for the detection of extended-spectrum β-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spin in a Belgian teaching hospital J Clin Microbiol 35 1997 2191 2197